Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Multiple Myeloma × abemaciclib × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Neuroblastoma 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Brain Neoplasms 2 Advanced Cancer 2 Urologic Neoplasms 1 Unilateral Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Multiple Myeloma 1 Metastatic Castration-Resistant Prostate Cancer 1 Mesothelioma, Malignant 1 Mesothelioma 1

Interventions

Dexamethasone 301 Bortezomib 201 Lenalidomide 160 Cyclophosphamide 144 Melphalan 136 Calcium Dobesilate 85 Peripheral Blood Stem Cell Transplantation 75 Thalidomide 67 fludarabine phosphate 61 Filgrastim 61 pomalidomide 50 carfilzomib 49 Granulocyte Colony-Stimulating Factor 49 daratumumab 47 ixazomib 44 Whole-Body Irradiation 44 Busulfan 43 Prednisone 42 Mycophenolic Acid 42 fludarabine 38 Tacrolimus 38 Cyclosporine 36 Antilymphocyte Serum 28 dexamethasone acetate 27 Etoposide 24 Radiotherapy 23 plerixafor 22 dexamethasone 21-phosphate 22 Bendamustine Hydrochloride 22 auricularum 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡